LMR Partners’s Gilead Sciences GILD Stock Holding History

LMR Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-125,000	Closed	-$10.1M	–	1213
2023 Q4	$10.1M	Buy	+125,000	New	+$9.73M	0.12%	199

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

LMR Partners's GILD Position: Q1 2026 in Review

LMR Partners sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 5,839 shares — an estimated $717K sold.

LMR Partners first reported a position in GILD in Q2 2014 and held it in 20 quarters. The position peaked at $5.87M in Q2 2020. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

LMR Partners reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
LMR Partners sold 5,839 Gilead Sciences shares in Q1 2026, an estimated $717K.
LMR Partners first reported a position in Gilead Sciences in Q2 2014 and held it in 20 quarters.
LMR Partners's Gilead Sciences position peaked at $5.87M in Q2 2020.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.